INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaJérôme Fayette, Helena Rebelo‐de‐Andrade, Amanda Psyrri et al.|Clinical Cancer Research|2025Cited by 26
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLCMarco Perna, Alessio Bruni, Vieri Scotti et al.|Clinical Lung Cancer|2021Cited by 11
Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic RegionsPanagiota Economopoulou, Paolo Bossi, Anastasios Pantazopoulos et al.|Cells|2021Cited by 11
A phase II trial of sorafenib (SOR) in patients (pts) with advanced cholangiocarcinoma (CC)Cristina Dealis, PierFranco Conte, Federica Bertolini et al.|Journal of Clinical Oncology|2008Cited by 7
Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE studyGiuseppe Lamberti, Andrea Ardizzoni, Karim Rihawi et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 5